Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Related press release
SAGE similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sage Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2014 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 6, 2015 | /s/ Jeffrey M. Jonas | |||||
Jeffrey M. Jonas, M.D. | ||||||
Chief Executive Officer, President and Director | ||||||
(Principal Executive Officer) | ||||||
Dated: March 6, 2015 | /s/ Kimi Iguchi | |||||
Kimi Iguchi | ||||||
Chief Financial Officer and Secretary | ||||||
(Principal Financial Officer) |